Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 75

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 75
---
 and to fix the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board providing for the issuance of such shares and as may be permitted by law, without stockholder approval. Our Board is able to determine, with respect to any series of preferred stock, the terms and rights of that series, including:

| ● | the                        
 designation of the series; |

| ● | the                             
 number of shares of the series; |

| ● | whether                                                                                               
 dividends, if any, will be cumulative or non-cumulative and the dividend rate, if any, of the series; |

| ● | the                                                
 dates at which dividends, if any, will be payable; |

| ● | the                                                                      
 redemption rights and price or prices, if any, for shares of the series; |

| ● | the                                                                                                    
 terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series; |

| ● | the                                                                                                                                
 amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the 
 affairs of our Company;                                                                                                            |

<div align='center'>21</div>

| ● | whether                                                                                                                             
 the shares of the series will be convertible into shares of any other class or series, or any other security, of our Company or any 
 other entity, and, if so, the specification of the other class or series or other security, the conversion price or prices or rate  
 or rates and provisions for any adjustments to such prices or rates, the date or dates as of which the shares will be convertible,  
 and all other terms and conditions upon which the conversion may be made;                                                           |

| ● | the                                                                                                                                   
 ranking of such series with respect to dividends and amounts payable on our liquidation, dissolution or winding-up, which may include 
 provisions that such series will rank senior to our common stock with respect to dividends and those distributions;                   |

| ● | restrictions                                                                  
 on the issuance of shares of the same series or any other class or series; or |

| ● | voting                                        
 rights, if any, of the holders of the series. |

The issuance of preferred stock could adversely affect, among other things, the voting power of holders of common stock and the